Ryan White HIV/AIDS Program States/Territories Part B Supplemental Grant Program

archived

This notice solicits applications for the Ryan White HIV/AIDS Program (RWHAP) States/Territories Part B Supplemental Grant Program. The purpose of this program is to supplement the HIV care and treatment services provided by the states/territories through the HIV Care Grant Program – RWHAP Part B States/Territories Formula and AIDS Drug Assistance Program (ADAP) Formula and ADAP Supplemental Awards. The awards support access to a comprehensive system of high quality HIV care and treatment services for low-income individuals and families living with HIV. The amount of funding awarded is determined by the state/territories’ ability to demonstrate the need in the state/territory based on an objective and quantified review process. Pursuant to section 2620(c) of the Public Health Service (PHS) Act, the Secretary prioritizes funds to states/territories to address the decline or disruption of services related to the decline in the amount of formula funding. Such a decline in funding is determined by comparing the amount of formula funding received in the current fiscal year (FY) to the amount received in FY 2006, and a state/territories’ assertion that such decline has had an impact on services available to all people living with HIV (PLWH) identified and eligible in the state/territory. RWHAP Part B supplemental funding is used in conjunction with the RWHAP Part B and ADAP grant funds awarded in FY 2017 for a 5-year project period (HRSA-17-036), to assist states/territories in developing and/or enhancing access to a comprehensive continuum of high quality care and treatment services for low-income individuals and families living with HIV. You must explain why RWHAP Part B supplemental funding is necessary to provide HIV care and treatment services for PLWH in the state/territory. You must describe how this supplemental funding will support viral suppression and achieve positive client-level health outcomes. You must demonstrate the severity of the HIV epidemic in the state/territory, using quantifiable data on epidemiology, co-morbidities, cost of care, the service needs of emerging populations, unmet need for core medical services, and unique service delivery challenges.

High